Dianthus Therapeutics, Inc. /DE/ Annual Operating Lease, Payments in USD from 2022 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Dianthus Therapeutics, Inc. /DE/ annual/quarterly Operating Lease, Payments history and growth rate from 2022 to 2024.
  • Dianthus Therapeutics, Inc. /DE/ Operating Lease, Payments for the quarter ending June 30, 2023 was $0.000, a 100% decline year-over-year.
  • Dianthus Therapeutics, Inc. /DE/ Operating Lease, Payments for the twelve months ending June 30, 2023 was $19.8M.
  • Dianthus Therapeutics, Inc. /DE/ annual Operating Lease, Payments for 2024 was $400K, unchanged from 2023.
  • Dianthus Therapeutics, Inc. /DE/ annual Operating Lease, Payments for 2023 was $400K, a 93.9% decline from 2022.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $400K $0 0% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-11
2023 $400K -$6.17M -93.9% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-11
2022 $6.57M Jan 1, 2022 Dec 31, 2022 10-K 2023-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.